Generic Pharmaceutical Manufacturing in the US - Market Research Report (2014-2029)
New York, United States
Last Updated: July 2024
NAICS 32541bRevenue
$50.3bn
Past 5-Year Growth
Profit
$X.Xbn
Employees
55,833
Businesses
465
Wages
$X.Xbn
Generic Pharmaceutical Manufacturing in the US industry analysis
Generic pharmaceuticals account for nine of every ten prescription drugs dispensed yearly. Generic pharmaceutical manufacturers are central to this supply and have an invaluable role in public health and saving patients and insurers billions. Despite this importance, the industry's revenue growth hinges on patent expirations, FDA approvals of new drug applications and competition from foreign companies and other domestic producers. In the last five years, revenue has been expanding at a CAGR of 1.3% to an estimated $50.3 billion, including expected growth of 0.7% in 2024. Maintaining prices at acceptable levels has been a significant challenge for additional revenue growth.
Trends and Insights
- Generic drugs account for a growing volume of prescriptions in the US. While generic penetration has been expanding, intense pricing pressures make developing profitable drugs challenging.
- Private insurance plans include generic drugs in their formularies for cost-savings. When insurers cover a generic manufacturer’s drug, the medication becomes accessible to a larger pool of patients, supporting high-volume sales.
- California’s pharmaceutical ecosystem positions the West as a major generics producer. Manufacturers benefit from the state’s world-class academic institutions, supportive policies, funding environment and strategic port access.
- A competitive pricing environment weakens profit. Generic pharmaceutical producers flood the market with generics once a branded patent expires, creating rapid price erosion as each vies for market share.
Industry Overview
Market size and recent performance (2014-2029)
Industry revenue has grown at a CAGR of 1.3 % over the past five years, to reach an estimated $50.3bn in 2024.
Trends and Insights
Patent expirations give buyers access to new generics
- Data from the FDA shows that hundreds of new generics received approval between 2018 and 2023. Generics save buyers millions of dollars each year (over $400.0 billion in 2022), making them invaluable to public health outcomes.
- Additional trends and insights available with purchase
Source: IBISWorld
Industry outlook (2024-2029)
Market size is projected to decline over the next five years.
Trends and Insights
The loss of exclusivity rights will present significant opportunities
- Despite losing their market share to brand name pharmaceutical manufacturers over the past five years, generic pharmaceutical manufacturers are expected to recover some of the lost revenue over the next five years, driven by the expiration of exclusivity rights on many brand name drugs.
Biggest companies in the Generic Pharmaceutical Manufacturing in the US
| Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd | 4,024.8 | -484.3 | -12.0 | |
Mylan Inc. | 3,063.2 | 68.3 | 2.2 | |
Hospira Inc. | 1,730.7 | 128.1 | 7.4 |
To view the market share and analysis for all 6 top companies in this industry, view purchase options.
Products & Services Segmentation
Source: IBISWorld
Industry revenue is measured across several distinct product and services lines, including Hypertension, Mental health and Pain. Hypertension is the largest segment of the Generic Pharmaceutical Manufacturing in the US.
Trends and Insights
Nearly half of US adults have high blood pressure
- Hypertension is a condition in which blood pressure is higher than normal. There are many drugs available to treat hypertension, including water pills, calcium channel blockers and renin inhibitors.
- More insights available in the full report
Widen you competitive advantage with related industries
Competitors
- Brand Name Pharmaceutical Manufacturing in the US
Complementors
- Cosmetic & Beauty Products Manufacturing in the US
- Drug, Cosmetic & Toiletry Wholesaling in the US
- Pharmacies & Drug Stores in the US
- Scientific Research & Development in the US
- Biotechnology in the US
International industries
- Global Pharmaceuticals & Medicine Manufacturing
- Pharmaceutical Product Manufacturing in Australia
- Pharmaceutical Preparations Manufacturing in the UK
- Pharmaceutical Preparations Manufacturing in Ireland
- Pharmaceutical Manufacturing in China
Table of Contents
About this industry
Industry definition
Generic pharmaceutical manufacturers produce medications that are bioequivalent to brand name drugs that regulatory agencies have already approved. Generic manufacturers create drugs that contain the same active ingredients, dosage form, strength and intended use as the original brand name drugs.
What's included in this industry?
Developing and producing generic drugsMarketing and distributing generic drugsGaining regulatory approval for generic drugsCompanies
Teva Pharmaceutical Industries LtdMylan Inc.Hospira Inc.Purchase this report to view all 6 major companies in this industry.
Related Terms
AUTHORIZED GENERICBIOPHARMACEUTICALSBIOSIMILARNEW DRUG APPLICATION (NDA)PATENT CLIFFIndustry Code
NAICS 325413 - Generic Pharmaceutical Manufacturing in the US
Performance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
Generic drugs account for a growing volume of prescriptions in the US. While generic penetration has been expanding, intense pricing pressures make developing profitable drug...
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
Private insurance plans include generic drugs in their formularies for cost-savings. When insurers cover a generic manufacturer’s drug, the medication becomes accessible to a...
In this chapter
- Products & Services
- Major Markets
- International Trade
Key metrics
- Largest market segment and value in 2024
- Product innovation level
- Total imports, level and trend
- Total exports, level and trend
- Trade Balance
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
- International trade, including imports by country and exports by country
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
- Recent trends in import and export volumes, country of origin or destination, and expected future trends
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
California’s pharmaceutical ecosystem positions the West as a major generics producer. Manufacturers benefit from the state’s world-class academic institutions, supportive po...
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each state
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each state in 2024
- Number and share of revenue each state accounts for in 2024
- Number and share of wages each state accounts for in 2024
- Number and share of employees in each state in 2024
Detailed analysis
- Geographic spread of the industry across North America, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
A competitive pricing environment weakens profit. Generic pharmaceutical producers flood the market with generics once a branded patent expires, creating rapid price erosion ...
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry’s own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
Teva is the largest generic pharmaceutical producer globally. The manufacturer’s combination of strategic initiatives, acquisitions, innovation and extensive product portfoli...
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
- Overview of Teva Pharmaceutical Industries Ltd's performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Mylan Inc.'s performance by revenue, market share and profit margin from 2018 through 2024
- Overview of Hospira Inc.'s performance by revenue, market share and profit margin from 2018 through 2024
- Overview of revenue, market share and profit margin trend for 3 additional companies
Detailed analysis
- Description and key data for Teva Pharmaceutical Industries Ltd, and factors influencing its performance in the industry
- Description and key data for Mylan Inc., and factors influencing its performance in the industry
- Description and key data for Hospira Inc., and factors influencing its performance in the industry
- Description, key data and performance trends for 3 additional companies
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Analyst insights
Regulatory agencies impose stringent requirements on generic drugs. Generic manufacturers must prove that their products meet the same high quality, safety and efficacy stand...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)
- Assistance historical data and forecast (2014-2029)
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Analyst insights
Generic producers depend on a complex global supply chain. Procuring inputs is essential for pharmaceutical production, but managing this cost has become increasingly challen...
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Industry Multiples (2017-2022)
- Industry Tax Structure (2017-2022)
- Income Statement (2017-2022)
- Balance Sheet (2017-2022)
- Liquidity Ratios (2017-2022)
- Coverage Ratios (2017-2022)
- Leverage Ratios (2017-2022)
- Operating Ratios (2017-2022)
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Methodology
How are IBISWorld reports created?
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do IBISWorld analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
- US Census Bureau
- US Bureau of Labor Statistics
- US International Trade Commission
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does IBISWorld forecast its data?
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Frequently Asked Questions
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Generic Pharmaceutical Manufacturing in the US industry in United States in 2024?
The market size of the Generic Pharmaceutical Manufacturing in the US industry in United States is $50.3bn in 2024.
How many businesses are there in the Generic Pharmaceutical Manufacturing in the US industry in 2024?
There are 465 businesses in the Generic Pharmaceutical Manufacturing in the US industry in United States, which has declined at a CAGR of 0.9 % between 2019 and 2024.
Has the Generic Pharmaceutical Manufacturing in the US industry in United States grown or declined over the past 5 years?
The market size of the Generic Pharmaceutical Manufacturing in the US industry in United States has been growing at a CAGR of 1.3 % between 2019 and 2024.
What is the forecast growth of the Generic Pharmaceutical Manufacturing in the US industry in United States over the next 5 years?
Over the next five years, the Generic Pharmaceutical Manufacturing in the US industry in United States is expected to decline.
What are the biggest companies in the Generic Pharmaceutical Manufacturing in the US market in United States?
The biggest companies operating in the Generic Pharmaceutical Manufacturing market in United States are Teva Pharmaceutical Industries Ltd, Mylan Inc. and Hospira Inc.
What does the Generic Pharmaceutical Manufacturing in the US in United States include?
Developing and producing generic drugs and Marketing and distributing generic drugs are part of the Generic Pharmaceutical Manufacturing in the US industry.
Which companies have the highest market share in the Generic Pharmaceutical Manufacturing in the US in United States?
The company holding the most market share in United States is Teva Pharmaceutical Industries Ltd.
How competitive is the Generic Pharmaceutical Manufacturing in the US industry in United States?
The level of competition is very high and increasing in the Generic Pharmaceutical Manufacturing in the US industry in United States.
